Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C
Open Access
- 15 November 2012
- journal article
- review article
- Published by Taylor & Francis in Virulence
- Vol. 3 (7) , 610-620
Abstract
Hepatitis C virus (HCV) is a small, enveloped RNA virus and a major cause of chronic liver disease. Resolution of primary HCV infections depends upon the vigorous responses of CD4+ and CD8+ T cells to multiple viral epitopes. Although such broad-based responses are readily detected early during the course of infection regardless of clinical outcome, they are not maintained in individuals who develop chronic disease. Ostensibly, a variety of factors contribute to the diminished T cell responses observed in chronic, HCV-infected patients including impaired dendritic cell function and the induction of CD4+FoxP3+ regulatory T cells. Overwhelming evidence suggests that the complex interaction of dendritic cells and regulatory T cells plays a critical role in the pathogenesis of chronic hepatitis C.Keywords
This publication has 139 references indexed in Scilit:
- Preserved MHC-II antigen processing and presentation function in chronic HCV infectionCellular Immunology, 2011
- The battle against immunopathology: infectious tolerance mediated by regulatory T cellsCellular and Molecular Life Sciences, 2011
- Selection-Driven Immune Escape Is Not A Significant Factor in the Failure of Cd4 T Cell Responses in Persistent Hepatitis C Virus InfectionHepatology, 2010
- How Tolerogenic Dendritic Cells Induce Regulatory T Cells2010
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?Immunity, 2009
- How regulatory T cells workNature Reviews Immunology, 2008
- Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen RecognitionImmunity, 2008
- The Foxp3+ regulatory T cell: a jack of all trades, master of regulationNature Immunology, 2008
- Differential dysfunction in dendritic cell subsets during chronic HCV infectionClinical Immunology, 2007
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992